Chang 2012.

Trial name or title	A randomised, double‐blind, placebo‐controlled trial of azithromycin versus amoxicillin‐clavulanic acid to treat mild to moderate respiratory exacerbations in children with non‐cystic fibrosis bronchiectasis, study one
Methods	Randomised, double‐blind, double‐dummy, placebo‐controlled, parallel‐group trial
Participants	Children aged less than 18 years, diagnosed with non‐cystic fibrosis bronchiectasis
Interventions	Arm 1: oral azithromycin 5 mg/kg x 1 for 14 days Arm 2: oral amoxicillin‐clavulanic acid 22.5 mg/kg x 2 for 14 days Arm 3: oral placebo for 14 days
Outcomes	Adverse events including data on antimicrobial resistance
Starting date	15 March 2012
Contact information	annechang@ausdoctors.net
Notes	Author reply in April 2018: Dr Anne Chang reports that the trial has completed recruitment and data are being analysed. No publication yet. Trial registration: Australia and New Zealand Clinical Trials Register ACTRN12612000011886